These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 30629195

  • 1. Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes.
    Wang H, Kuang J, Xu M, Gao Z, Li Q, Liu S, Zhang F, Yu Y, Liang Z, Zhao W, Yang G, Li L, Wang Y, Li G.
    J Clin Endocrinol Metab; 2019 Jun 01; 104(6):2153-2162. PubMed ID: 30629195
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
    Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.
    Diabetes Care; 2004 Nov 01; 27(11):2597-602. PubMed ID: 15504992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
    Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y.
    Diabetes Technol Ther; 2012 Sep 01; 14(9):756-61. PubMed ID: 22731793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.
    Yuan G, Hu H, Wang S, Yang Q, Yu S, Sun W, Qian W, Mao C, Zhou L, Chen D, Wang Z, Gong Q, Wang D.
    Endocr J; 2015 Sep 01; 62(9):817-34. PubMed ID: 26194272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
    Ke W, Liu L, Liu J, Chen A, Deng W, Zhang P, Cao X, Liao Z, Xiao H, Liu J, Li Y.
    J Diabetes Res; 2016 Sep 01; 2016():6839735. PubMed ID: 26640805
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP, Mo H, Liu BL, Tang WL, Deng XG, Su X, Yao L, Lin J, Feng Q, Peng J, Zhou ZG, Li YJ.
    Zhonghua Nei Ke Za Zhi; 2010 May 01; 49(5):405-9. PubMed ID: 20646415
    [Abstract] [Full Text] [Related]

  • 16. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes.
    Lin XH, Xu MT, Tang JY, Mai LF, Wang XY, Ren M, Yan L.
    Lipids Health Dis; 2016 Nov 23; 15(1):203. PubMed ID: 27881128
    [Abstract] [Full Text] [Related]

  • 17. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity.
    Li K, Li L, Yang M, Liu H, Liu D, Yang H, Boden G, Yang G.
    Eur J Endocrinol; 2011 Jun 23; 164(6):905-10. PubMed ID: 21471167
    [Abstract] [Full Text] [Related]

  • 18. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.
    Diabetes; 1999 Dec 23; 48(12):2414-21. PubMed ID: 10580431
    [Abstract] [Full Text] [Related]

  • 19. Baseline red blood cell distribution width predicts long-term glycemic remission in patients with type 2 diabetes.
    Xu L, Wang L, Huang X, Liu L, Ke W, He X, Huang Z, Liu J, Wan X, Cao X, Li Y.
    Diabetes Res Clin Pract; 2017 Sep 23; 131():33-41. PubMed ID: 28672172
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.
    Yuan G, Jia J, Zhang C, Yu S, Dong S, Ye J, Zhu T, Tang B, Qian W, Wang D, Yang L, Zhou L, Mao C.
    Endocr J; 2014 Sep 23; 61(5):513-21. PubMed ID: 24621778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.